MARKET

RICFY

RICFY

Recordati Industria Chimica e Farmaceutica SpA
OTCPK
14.75
NaN%
Closed 15:54 05/28 EDT
OPEN
--
PREV CLOSE
14.75
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
15.82
52 WEEK LOW
10.16
MARKET CAP
12.00B
P/E (TTM)
22.20
1D
5D
1M
3M
1Y
5Y
1D
Recordati reports Q1 results
Seeking Alpha · 05/13 12:47
Recordati Q1 Net Income Rises; Confirms 2026 Financial Targets
NASDAQ · 05/13 03:48
Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
TipRanks · 04/23 01:35
Kepler Capital Remains a Buy on Recordati Industria Chimica e Farmaceutica SPA (0KBS)
TipRanks · 03/28 04:55
Recordati Industria initiated with an Outperform at BNP Paribas
TipRanks · 03/03 09:30
Kepler Capital Sticks to Their Buy Rating for Recordati Industria Chimica e Farmaceutica SPA (0KBS)
TipRanks · 02/20 03:25
Recordati reports FY2025 results
Seeking Alpha · 02/18 18:34
Recordati Industria upgraded to Equal Weight from Underweight at Barclays
TipRanks · 02/12 11:52
More
About RICFY
Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

Webull offers Recordati Industria Chmc Frmctc SpA stock information, including OTCPK: RICFY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RICFY stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RICFY stock methods without spending real money on the virtual paper trading platform.